SEC Form 4 · accession 0000950138-17-000212
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Ian J Watkins
Officer — Chief HR Officer
Period of report
Feb 17, 2017
Accepted (ET)
Feb 21, 2017 · 8:50 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Feb 17, 2017 | P | 375 | $54.26 | D | 26,921 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 162 shares acquired on December 31, 2016, under the Mallinckrodt employee stock purchase plan.
- F2Total number of shares was previously overstated by 40 shares. The total has been corrected on this Form 4.